Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 436 AL 450

PUBMED

Longitudinal microPET imaging of the zQ175 mouse model of Huntington's disease shows in vivo changes of molecular targets in the striatum and the cerebral cortex.

Häggkvist J, Tóth M, Tari L, Varnäs K, Svedberg M, Forsberg A, Nag S, Dominguez C, Munoz-Sanjuan I, Bard J, Wityak J, Varrone A, Halldin C, Mrzljak L.

J Nucl Med. 2016 Nov 10. pii: jnumed.116.180497. [Epub ahead of print]

0

0

0

PUBMED

Identification of extreme motor phenotypes in Huntington's disease.

Braisch U, Hay B, Muche R, Rothenbacher D, Landwehrmeyer GB, Long JD, Orth M; REGISTRY Investigators of the European Huntington's Disease Network and COHORT Investigators of the Huntington Study Group

Am J Med Genet B Neuropsychiatr Genet. 2016 Nov 21. doi: 10.1002/ajmg.b.32514. [Epub ahead of print]

0

0

0

PUBMED

Effects of Anthocyanins on CAG Repeat Instability and Behaviour in Huntington's Disease R6/1 Mice.

Møllersen L, Moldestad O, Rowe AD, Bjølgerud A, Holm I, Tveterås L, Klungland A, Retterstøl L.

PLoS Curr. 2016 Jul 5;8. pii: ecurrents.hd.58d04209ab6d5de0844db7ef5628ff67. doi: 10.1371/currents.hd.58d04209ab6d5de0844db7ef5628ff67.

0

0

0

PUBMED

Huntington disease: a single-gene degenerative disorder of the striatum.

Nopoulos PC.

Dialogues Clin Neurosci. 2016 Mar;18(1):91-8. Review.

0

0

0

PUBMED

Guidelines for clinical pharmacological practices in Huntington's disease.

Désaméricq G, Youssov K, Charles P, Saleh N, Olivier A, Sherer-Gagou C, Verny C; multidisciplinary working group., Bachoud-Lévi AC.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):423-432. doi: 10.1016/j.neurol.2016.07.012.

0

0

0

PUBMED

Impulsivity trait in the early symptomatic BACHD transgenic rat model of Huntington disease.

Manfré G, Doyère V, Bossi S, Riess O, Nguyen HP, El Massioui N.

Behav Brain Res. 2016 Feb 15;299:6-10. doi: 10.1016/j.bbr.2015.11.007.

0

0

0

PUBMED

Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.

Mestre TA, van Duijn E, Davis AM, Bachoud-Lévi AC, Busse M, Anderson KE, Ferreira JJ, Mahlknecht P, Tumas V, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P; Members of the MDS Committee o

Mov Disord. 2016 Oct;31(10):1466-1478. doi: 10.1002/mds.26675. Review.

0

0

0

PUBMED

Large-scale brain network abnormalities in Huntington's disease revealed by structural covariance.

Minkova L, Eickhoff SB, Abdulkadir A, Kaller CP, Peter J, Scheller E, Lahr J, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S; TRACK-HD Investigators..

Hum Brain Mapp. 2016 Jan;37(1):67-80. doi: 10.1002/hbm.23014.

0

0

0

PUBMED

Do I misconstrue? Sarcasm detection, emotion recognition, and theory of mind in Huntington disease.

Larsen IU, Vinther-Jensen T, Gade A, Nielsen JE, Vogel A.

Neuropsychology. 2016 Feb;30(2):181-9. doi: 10.1037/neu0000224.

0

0

0

PUBMED

Changes in mental state and behaviour in Huntington's disease.

Eddy CM, Parkinson EG, Rickards HE.

Lancet Psychiatry. 2016 Nov;3(11):1079-1086. doi: 10.1016/S2215-0366(16)30144-4. Review.

0

0

0

PUBMED

Reply to: Double trouble progressive external ophthalmoplegia and Huntington's disease.

Filosto M, Santorelli FM.

Mol Genet Metab Rep. 2016 May 17;7:93. doi: 10.1016/j.ymgmr.2016.05.002. No abstract available.

0

0

0

PUBMED

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Huntington Study Group PHAROS Investigators., Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E,

JAMA Neurol. 2016 Jan;73(1):102-10. doi: 10.1001/jamaneurol.2015.2736.

0

0

0

PUBMED

Cognitive training modifies disease symptoms in a mouse model of Huntington's disease.

Yhnell E, Lelos MJ, Dunnett SB, Brooks SP.

Exp Neurol. 2016 Aug;282:19-26. doi: 10.1016/j.expneurol.2016.05.008.

0

0

0

PUBMED

Mid- and long-term anxiety levels associated with presymptomatic testing of Huntington's disease, Machado-Joseph disease, and familial amyloid polyneuropathy.

Lêdo S, Leite Â, Souto T, Dinis MA, Sequeiros J.

Rev Bras Psiquiatr. 2016 Feb 5;38(2):113-20. doi: 10.1590/1516-4446-2014-1617.

0

0

0

PUBMED

Deutetrabenazine for Treatment of Chorea in Huntington Disease.

Geschwind MD, Paras N.

JAMA. 2016 Jul 5;316(1):33-5. doi: 10.1001/jama.2016.8011. No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy